⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Candesartan

کاندسارتان

⚠ Unverified

❤️ Cardiovascular SystemAngiotensin II receptor blocker

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Dangerous / avoid 👶 Children:Use with caution 🇮🇷 Registered in Iran ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA091390 ATC C09CA06

Market / country: 🇺🇸 USA

Atacand (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Candesartan · 2.1

• Range 8–32 mg/day. FDA Candesartan · 2.1

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity to candesartan. FDA Candesartan · 4
⛔ Children under 1 year must not receive it. FDA Candesartan · 2.2

Warnings

• Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Candesartan · Boxed Warning

Formulations

4 mg tablet (scored) — tablet 🇺🇸 USA FDA Candesartan · 3
8 mg tablet — tablet 🇺🇸 USA FDA Candesartan · 3
16 mg tablet — tablet 🇺🇸 USA FDA Candesartan · 3
32 mg tablet — tablet 🇺🇸 USA FDA Candesartan · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Candesartan · Boxed Warning
“WARNING: FETAL TOXICITY See Full Prescribing Information for complete boxed warning.”
🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Candesartan · 8.2
“Because of the potential for serious adverse reactions in breastfed infants, advise a nursing woman that breastfeeding is not recommended during treatment with candesartan cilexetil [see Warnings and Precautions ( 5.2 )] .”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Candesartan · 8.4
“The antihypertensive effects of candesartan cilexetil were evaluated in hypertensive children 1 to < 17 years of age in randomized, double-blind clinical studies [see Clinical Studies ( 14.1 )].”
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA091390
DailyMed (FDA label)FDA Candesartan
MedlinePlus (NIH)Candesartan
WHO ATC/DDDC09CA06
Darooyab (Iran)Candesartan

🇮🇷 Registered in Iran Darooyab · G-1578/Candesartan

Dosage forms with Iranian generic codes, per Darooyab.

08854 · CANDESARTAN 16MG TAB · قرص کاندسارتان ۱۶ میلی‌گرم
08851 · CANDESARTAN 2MG TAB · قرص کاندسارتان ۲ میلی‌گرم
08855 · CANDESARTAN 32MG TAB · قرص کاندسارتان ۳۲ میلی‌گرم
08852 · CANDESARTAN 4MG TAB · قرص کاندسارتان ۴ میلی‌گرم
08853 · CANDESARTAN 8MG TAB · قرص کاندسارتان ۸ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Candesartan · 3 FDA Candesartan · 2.1 FDA Candesartan · 2.2 FDA Candesartan · 4 FDA Candesartan · Boxed Warning FDA Candesartan · 8.2 FDA Candesartan · 8.4 FDA Candesartan · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1578/Candesartan
Clinical review⚠ Unverified